AlphaMaven AlphaMaven

NovaCare Rehabilitation’s parent, Select Medical, was sold in $3.9 billion private equity deal

Reported by Inquirer
Jul 3, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Select Medical Holdings Corporation completed a $3.9 billion go-private transaction at $16.50 per share, with the deal representing approximately $1.7 billion in equity consideration for outstanding common shares.
  • • The acquisition consortium is led by co-founder and insider Robert A. Ortenzio, alongside Martin F. Jackson and WCAS (Windy City Partners), combining insider leadership with established private equity backing.
  • • Select Medical's NYSE listing was delisted on July 1, 2026, marking the company's transition from public to privately held status following the transaction's completion.
  • • NovaCare Rehabilitation, Select Medical's flagship physical therapy subsidiary acquired in 1999, operates over 100 locations across the Philadelphia region and partnerships with Rothman Orthopaedics, positioning the combined entity as a significant player in rehabilitation services.
  • • The take-private structure reflects insider confidence in the company's value, with founders and management joining institutional capital to execute a deleveraging and operational restructuring outside public market scrutiny.
Summary
Select Medical Holdings Corporation completed a $3.9 billion private equity acquisition that returned the Mechanicsburg-based healthcare services provider to private ownership, ending its public trading tenure on the New York Stock Exchange on July 1, 2026. The transaction valued the company at $16.50 per share, representing approximately $1.7 billion in aggregate equity consideration for outstanding common shares, with the remainder of enterprise value reflecting debt assumptions and transaction costs.

The acquisition consortium combines insider leadership with institutional private equity expertise. Co-founder Robert A. Ortenzio and executive Martin F. Jackson led the investor group alongside WCAS, a private equity firm with established healthcare sector experience. This structure—combining founder-led insider participation with professional capital—signals management's confidence in the company's operational potential outside public market pressures and provides alignment of interests between operators and financial sponsors.

Select Medical's core asset, NovaCare Rehabilitation, represents a substantial platform within the outpatient physical therapy and occupational health market. Originally acquired in 1999, NovaCare operates over 100 physical therapy locations concentrated in the Philadelphia region, with strategic partnerships including a collaboration with Rothman Orthopaedics, a leading regional orthopedic system. This combination of owned facilities and partnership networks positions the privately held entity to pursue operational consolidation, geographic expansion, and clinical integration strategies that may be constrained under public company governance.

The go-private transaction exemplifies institutional investor appetite for mature healthcare services platforms with recurring revenue, established referral networks, and operational improvement opportunities. By transitioning to private ownership, Select Medical gains flexibility to pursue longer-term value creation initiatives, including potential add-on acquisitions within rehabilitation services, operational cost optimization, and strategic partnerships—strategies that align with typical private equity playbooks in fragmented healthcare subsectors.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Inquirer NovaCare Rehabilitation’s parent, Select Medical, was sold in $3.9 billion private equity deal